Pascal Touchon - 16 Aug 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
16 Aug 2023
Net transactions value
-$50,835
Form type
4
Filing time
18 Aug 2023, 18:25:18 UTC
Previous filing
29 Jun 2023
Next filing
20 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $35,406 -21,432 -3% $1.65 685,239 16 Aug 2023 Direct F1, F2
transaction ATRA Common Stock Sale $15,429 -9,334 -1.4% $1.65 675,905 16 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.